Overexpression of Wilms tumor 1 gene as a negative prognostic indicator in acute myeloid leukemia.
Chromosomal aberrations are useful in assessing treatment options and clinical outcomes of acute myeloid leukemia (AML) patients. However, 40 ∼ 50% of the AML patients showed no chromosomal abnormalities, i.e., with normal cytogenetics aka the CN-AML patients. Testing of molecular aberrations such a...
Guardado en:
Autores principales: | Xiaodong Lyu, Yaping Xin, Ruihua Mi, Jing Ding, Xianwei Wang, Jieying Hu, Ruihua Fan, Xudong Wei, Yongping Song, Richard Y Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c20a92c0ec54df1ab7d862bd272c924 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia
por: Can Yue, et al.
Publicado: (2021) -
Development of a poor-prognostic-mutations derived immune prognostic model for acute myeloid leukemia
por: Feng-Ting Dao, et al.
Publicado: (2021) -
Survival prognostic factors in patients with acute myeloid leukemia using machine learning techniques.
por: Keyvan Karami, et al.
Publicado: (2021) -
The long non-coding RNA CDK6-AS1 overexpression impacts on acute myeloid leukemia differentiation and mitochondrial dynamics
por: Elena Porcù, et al.
Publicado: (2021) -
TRIM25 contributes to the malignancy of acute myeloid leukemia and is negatively regulated by microRNA-137
por: Wang Sheng, et al.
Publicado: (2020)